Rationale for sentinel node biopsy to stage NO head and neck squamous-cell carcinoma

被引:6
作者
Ross, G [1 ]
机构
[1] Canniesburn Hosp, Plast Surg Unit, Glasgow, Lanark, Scotland
关键词
sentinel node biopsy; head and neck cancer; squamous-cell carcinoma; micrometastases; neck dissection;
D O I
10.1089/1084978041424963
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sentinel node biopsy is an evolving staging tool in the management of patients with squamous-cell carcinoma of the head and neck. This tool provides a more detailed understanding of the lymphatic pathways within the head and neck and the role of these pathways regarding tumor spreading. By targeting nodes that are most likely to harbor disease, a more detailed pathological evaluation of sentinel nodes is possible-thus improving staging by the identification of micrometastases. The rationale behind the use of sentinel node biopsy to stage the N0 neck are discussed within this paper.
引用
收藏
页码:273 / 284
页数:12
相关论文
共 138 条
[1]  
Alex J C, 1996, Surg Oncol Clin N Am, V5, P33
[2]   Sentinel lymph node radiolocalization in head and neck squamous cell carcinoma [J].
Alex, JC ;
Sasaki, CT ;
Krag, DN ;
Wenig, B ;
Pyle, PB .
LARYNGOSCOPE, 2000, 110 (02) :198-203
[3]   GAMMA-PROBE GUIDED LOCALIZATION OF LYMPH-NODES [J].
ALEX, JC ;
KRAG, DN .
SURGICAL ONCOLOGY-OXFORD, 1993, 2 (03) :137-143
[4]  
Ambrosch P, 1996, Oncology (Williston Park), V10, P1221
[5]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[6]  
BARTELINK H, 1983, CANCER-AM CANCER SOC, V52, P1008, DOI 10.1002/1097-0142(19830915)52:6<1008::AID-CNCR2820520613>3.0.CO
[7]  
2-B
[8]  
Beenken SW, 1999, HEAD NECK-J SCI SPEC, V21, P124, DOI 10.1002/(SICI)1097-0347(199903)21:2<124::AID-HED5>3.0.CO
[9]  
2-A
[10]  
Bilchik AJ, 1998, CANCER J SCI AM, V4, P351